PLoS One 11:e0142481
2024, doi: 10.1016/j.ajem.2024.01.010
What Regulators Say After extensive review, regulatory agencies have concluded: No confirmed causal link between GLP-1 medications and anger or aggression No black box warnings related to mood Continued monitoring is appropriate This reflects a balanced interpretation of available evidencenot dismissal of patient experiences, but also not overstating risk
Since the progression to invasive PDAC is believed to take more than a decade, the follow-up periods in many cohort studies and randomized controlled trials (where it is typically 12 years) are insufficient to understand the long-term effects
Robin Wenzel, Head of Wells Fargo Agri-Food Institute Courtney Buerger Schmidt, Sector Manager Robin Wenzel is a Senior Vice President and the Head of Wells Fargos Agri-Food Institute, a team of national industry advisors providing economic insights, analytics, research, and reporting across the agribusiness, food, and beverage spectrum
We want to kind of understand who these drugs are for and what we know about how they're working